AGCT1532 - Phase 3 Accelerated BEP Trial: A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours A Phase 2 ...

Not all laser facials are created equal, though. Sifting through the claims, the complex science and the different categories ...

The global energy-based non-invasive medical aesthetic treatment system market is experiencing significant growth, driven by advancements in technology and increasing consumer demand for non-invasive ...

Laser treatments offer effective solutions for acne scars by targeting deeper skin layers, diminishing inflammation and promoting collagen production.

The Atherectomy Devices Market, valued at USD 1.2 billion in 2022, is projected to reach USD 2.5 billion by 2032, registering a CAGR of 8% from 2023 to 2032. This growth can be attributed to several ...

Shankar Siva and colleagues1 published their findings on the use of stereotactic ablative radiotherapy (SABR) in primary ...

In our trial, only 24 (34%) of 70 patients had T1a primary tumour and received single-session stereotactic ablative body ...

The 3-Dimensional Multifunctional Ablative Thermal Protection System (3D-MAT) is a thermal protection material developed as a ...

MAT technology stands as a cornerstone in the success of contemporary and future space missions. The 3-Dimensional ...

Alma, a global leader in energy-based medical and aesthetic solutions, announced the commercial debut of Alma Harmony, the ...

Hopkins researchers develop a "one-stop shop” capsule for diagnosing and treating Barrett's esophagus, a condition known to ...

Local ablative therapy, such as radiotherapy or surgery, plays a key role in treatment of patients with oligometastatic disease. Stereotactic ablative body radiotherapy (SABR) comes to the fore as a ...